Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 +0.53%63 EV-to-FCF is 23.77 as of Jul. 15, 2026, which is 52% above its 10-year median of 15.68. GuruFocus rates TSE:3353 with a GF Score™ of 63/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 354 Conglomerates companies, Medical Ikkou Group Co ranks worse than 63.28% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medical Ikkou Group Co's Enterprise Value is 円15,595 Mil.
Medical Ikkou Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was 円656 Mil. Therefore, Medical Ikkou Group Co's EV-to-FCF for today is 23.77.
The historical rank and industry rank for Medical Ikkou Group Co's EV-to-FCF or its related term are showing as below:
TSE:3353'
s EV-to-FCF Range Over the Past 10 Years
Min: -39.85 Med: 15.68 Max: 151.38
Current: 23.81
During the past 13 years, the highest EV-to-FCF of Medical Ikkou Group Co was 151.38. The lowest was -39.85. And the median was 15.68.
TSE:3353's EV-to-FCF is ranked worse than 63.28% of 354
companies
in the Conglomerates industry
Industry Median: 17.635
vs TSE:3353: 23.81
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Ikkou Group Co (TSE:3353) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Medical Ikkou Group Co's PE Ratio (TTM) for today is calculated as:
Medical Ikkou Group Co's share price for today is 円2841.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was 円338.730.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co EV-to-FCF vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's EV-to-FCF falls into.
Medical Ikkou Group Co's current Enterprise Value is 円15,595 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medical Ikkou Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2026 was 円656 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a EV-to-FCF of 23.77 as of Jul. 15, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Ikkou Group Co and its competitors. This is 52% above median its historical median of 15.68. According to the industry distribution chart, Medical Ikkou Group Co ranks #224 out of 354 companies in the Conglomerates industry, placing it in the top 63.3%.
Is Medical Ikkou Group Co's EV-to-FCF too high?
Medical Ikkou Group Co's current EV-to-FCF of 23.77 is 52% above median its 10-year median of 15.68. The Conglomerates industry median EV-to-FCF is 17.64. Medical Ikkou Group Co's value of 23.77 is 34.8% above this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #224 out of 354 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's EV-to-FCF compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #224 out of 354 companies for EV-to-FCF. This places Medical Ikkou Group Co in the lower half of its industry. The industry median EV-to-FCF is 17.64. Medical Ikkou Group Co's value of 23.77 is 34.8% above this benchmark. While the company's 10-year median is 15.68 vs. the industry median of 17.64, Medical Ikkou Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Conglomerates company?
The median EV-to-FCF among Conglomerates companies is 17.64, based on 354 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current EV-to-FCF of 23.77 is 34.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median EV-to-FCF is 17.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current EV-to-FCF is 23.77, which is 52% above median its own 10-year median of 15.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current EV-to-FCF is 23.77, which is 52% above median its 10-year median of 15.68 and 34.8% above the Conglomerates industry median of 17.64. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current EV-to-FCF is 23.77 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
EV-to-FCF: 23.77 (52% above median its 10-year median of 15.68)
GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
Industry Position: 34.8% above the Conglomerates median (#224 of 354)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score
Get the complete analysis for TSE:3353
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
